Krux
March 21, 2026
No Evidence of Verily's Rumored $300M Funding Round
Published: March 21, 2026 at 12:37 AM
Updated: March 21, 2026 at 12:37 AM
100-word summary
A claimed $300 million Series X Capital-led investment in Verily can't be verified. The Alphabet-owned health tech company's last confirmed funding was $700 million in December 2020, following a $1 billion round in 2019. No press release or public filing supports the new round. What is real: Verily sold its insurance unit to Elevance Health this year, signaling a retreat from insurance brokerage to focus on precision health platforms. The timing is curious. Verily's 2020 round attracted heavyweight backers like Temasek and Ontario Teachers' Pension Plan. If a new $300 million round actually closed, staying quiet would be unusual for a company that previously announced far larger raises.
What happened
A claimed $300 million Series X Capital-led investment in Verily can't be verified. The Alphabet-owned health tech company's last confirmed funding was $700 million in December 2020, following a $1 billion round in 2019. No press release or public filing supports the new round. What is real: Verily sold its insurance unit to Elevance Health this year, signaling a retreat from insurance brokerage to focus on precision health platforms. The timing is curious. Verily's 2020 round attracted heavyweight backers like Temasek and Ontario Teachers' Pension Plan.
Why it matters
If a new $300 million round actually closed, staying quiet would be unusual for a company that previously announced far larger raises.